転移性大腸癌に対するS-1,Irinotecan,Bevacizumab併用化学療法(IRIS+Bevacizumab)の第II相臨床試験

2014 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []